Fred A Middleton

CIK 1267959 · View on SEC EDGAR ↗

Insider

First SEC filing: Feb. 2, 2011 · Latest: Feb. 2, 2011

On this page

Insider at

Insider transactions

1 buys (P) 0 sells (S) Net: $199,178 + 61 non-open-market transactions below Avg return of open purchases vs now: -28.1% last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

61 other filings hidden
Date Ticker Code Shares Price Value Owned after Δ own A/D vs now
June 25, 2026 CALC P 248,972 $0.80 $199,178 1,063,272 Indirect +30.57% Acquired -28.1% (price as of 2026-08-20)
June 9, 2023 CALC P 714 $5.20 $3,713 11,714 Direct +6.49% Acquired -88.9% (price as of 2026-08-20)
June 7, 2023 CALC P 500 $5.20 $2,600 11,000 Direct +4.76% Acquired -88.9% (price as of 2026-08-20)
June 6, 2023 CALC P 500 $4.88 $2,440 10,500 Direct +5.00% Acquired -88.2% (price as of 2026-08-20)
May 19, 2023 CALC P 10,000 $2.85 $28,500 10,000 Direct — Acquired -79.8% (price as of 2026-08-20)
June 24, 2013 PCRX S 10b5-1 5,900 $28.70 $169,330 0 Indirect -100.00% Disposed -16.1% (price as of 2026-08-20)
June 21, 2013 PCRX S 10b5-1 2,828 $28.49 $80,570 5,900 Indirect -32.40% Disposed -15.5% (price as of 2026-08-20)
June 21, 2013 PCRX S 10b5-1 36,374 $29.22 $1,062,848 8,728 Indirect -80.65% Disposed -17.6% (price as of 2026-08-20)
June 21, 2013 PCRX S 10b5-1 2,222 $28.49 $63,305 0 Indirect -100.00% Disposed -15.5% (price as of 2026-08-20)
June 21, 2013 PCRX S 10b5-1 28,576 $29.22 $834,991 2,222 Indirect -92.79% Disposed -17.6% (price as of 2026-08-20)
June 20, 2013 PCRX S 10b5-1 66,100 $28.93 $1,912,273 30,798 Indirect -68.22% Disposed -16.7% (price as of 2026-08-20)
June 19, 2013 PCRX S 10b5-1 48,400 $29.76 $1,440,384 96,898 Indirect -33.31% Disposed -19.1% (price as of 2026-08-20)
June 18, 2013 PCRX S 10b5-1 29,600 $29.48 $872,608 145,298 Indirect -16.92% Disposed -18.3% (price as of 2026-08-20)
Nov. 21, 2011 PCRX P 10,000 $6.50 $65,000 10,000 Direct — Acquired 270.5% (price as of 2026-08-20)
Feb. 8, 2011 PCRX P 46,379 $7.00 $324,653 46,379 Indirect — Acquired 244.1% (price as of 2026-08-20)
Feb. 8, 2011 PCRX P 27,931 $7.00 $195,517 27,931 Indirect — Acquired 244.1% (price as of 2026-08-20)
Feb. 8, 2011 PCRX P 4,297 $7.00 $30,079 4,297 Indirect — Acquired 244.1% (price as of 2026-08-20)
Feb. 8, 2011 PCRX P 5,119 $7.00 $35,833 5,119 Indirect — Acquired 244.1% (price as of 2026-08-20)
Feb. 8, 2011 PCRX P 184,131 $7.00 $1,288,917 184,131 Indirect — Acquired 244.1% (price as of 2026-08-20)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date Ticker Security Underlying Exercise price Expiration Shares A/D
May 8, 2023 CALC Director Stock Option (Right to Buy) Common Stock (20,000) $3.25 May 7, 2033 20,000 Acquired
March 20, 2023 CALC Warrant Common Stock (167) $27.94 June 25, 2026 167 Acquired
March 20, 2023 CALC Warrant Common Stock (113) $27.94 March 4, 2026 113 Acquired
March 20, 2023 CALC Warrant Common Stock (840) $27.94 June 25, 2026 840 Acquired
March 20, 2023 CALC Warrant Common Stock (569) $27.94 March 4, 2026 569 Acquired
March 20, 2023 CALC Warrant Common Stock (3,249) $27.94 June 25, 2026 3,249 Acquired
March 20, 2023 CALC Warrant Common Stock (2,203) $27.94 March 4, 2026 2,203 Acquired
March 20, 2023 CALC Warrant Common Stock (12,380) $27.94 June 25, 2026 12,380 Acquired
March 20, 2023 CALC Warrant Common Stock (8,393) $27.94 Feb. 22, 2026 8,393 Acquired
March 20, 2023 CALC Warrant Common Stock (183) $27.94 June 25, 2026 183 Acquired
March 20, 2023 CALC Warrant Common Stock (237) $27.94 March 4, 2026 237 Acquired
March 20, 2023 CALC Warrant Common Stock (15,403) $27.94 June 25, 2026 15,403 Acquired
March 20, 2023 CALC Warrant Common Stock (6,852) $27.94 Feb. 22, 2026 6,852 Acquired
March 20, 2023 CALC Warrant Common Stock (1,910) $26.74 Feb. 28, 2027 1,910 Acquired
March 20, 2023 CALC Warrant Common Stock (2,685) $27.94 June 25, 2026 2,685 Acquired
March 20, 2023 CALC Warrant Common Stock (16,539) $27.94 Feb. 22, 2026 16,539 Acquired
March 20, 2023 CALC Warrant Common Stock (2,672) $26.74 Feb. 28, 2027 2,672 Acquired
March 20, 2023 CALC Warrant Common Stock (5,760) $10.42 Oct. 24, 2032 5,760 Acquired
June 12, 2013 PCRX Stock Option (Right to Buy) Common Stock (7,000) $29.20 June 11, 2023 7,000 Acquired
June 5, 2012 PCRX Common Stock Common Stock (7,000) $10.81 June 4, 2022 7,000 Acquired
June 2, 2011 PCRX Stock option (right to buy) Common Stock (15,692) $13.98 June 2, 2021 15,692 Acquired
Feb. 8, 2011 PCRX Series A Convertible Preferred Stock Common Stock (736,583) — — 736,583 Disposed
Feb. 8, 2011 PCRX Series A Convertible Preferred Stock Common Stock (14,877) — — 14,877 Disposed
Feb. 8, 2011 PCRX Series A Convertible Preferred Stock Common Stock (24,871) — — 24,871 Disposed
Feb. 8, 2011 PCRX Series A Convertible Preferred Stock Common Stock (29,634) — — 29,634 Disposed
Feb. 8, 2011 PCRX Series A Convertible Preferred Stock Common Stock (681,715) — — 681,715 Disposed
Feb. 8, 2011 PCRX Convertible Promissory Notes Common Stock (344,355) — — 344,355 Disposed
Feb. 8, 2011 PCRX Convertible Promissory Notes Common Stock (12,058) — — 12,058 Disposed
Feb. 8, 2011 PCRX Convertible Promissory Notes Common Stock (14,366) — — 14,366 Disposed
Feb. 8, 2011 PCRX Convertible Promissory Notes Common Stock (341,788) — — 341,788 Disposed
Feb. 8, 2011 PCRX Convertible Promissory Notes Common Stock (129,445) — — 129,445 Disposed
Feb. 8, 2011 PCRX Convertible Promissory Notes Common Stock (4,533) — — 4,533 Disposed
Feb. 8, 2011 PCRX Convertible Promissory Notes Common Stock (5,400) — — 5,400 Disposed
Feb. 8, 2011 PCRX Convertible Promissory Notes Common Stock (128,479) — — 128,479 Disposed

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 27 holdings

Securities held when first becoming an insider, per SEC Form 3.

Date Ticker Security Shares Ownership
Feb. 2, 2011 PCRX Common Stock 125,800 Indirect
Feb. 2, 2011 PCRX Common Stock 55,788 Indirect
Feb. 2, 2011 PCRX Common Stock 1,995 Indirect
Feb. 2, 2011 PCRX Common Stock 2,377 Indirect
Feb. 2, 2011 PCRX Series A Convertible Preferred Stock→ Common Stock (736,583) 736,583 Indirect
Feb. 2, 2011 PCRX Series A Convertible Preferred Stock→ Common Stock (14,877) 14,877 Indirect
Feb. 2, 2011 PCRX Series A Convertible Preferred Stock→ Common Stock (24,871) 24,871 Indirect
Feb. 2, 2011 PCRX Series A Convertible Preferred Stock→ Common Stock (29,634) 29,634 Indirect
Feb. 2, 2011 PCRX Series A Convertible Preferred Stock→ Common Stock (681,715) 681,715 Indirect
Feb. 2, 2011 PCRX Common Stock Warrant (Right to Buy)→ Common Stock (17,973) 17,973 Indirect
Feb. 2, 2011 PCRX Common Stock Warrant (Right to Buy)→ Common Stock (629) 629 Indirect
Feb. 2, 2011 PCRX Common Stock Warrant (Right to Buy)→ Common Stock (749) 749 Indirect
Feb. 2, 2011 PCRX Common Stock Warrant (Right to Buy)→ Common Stock (17,839) 17,839 Indirect
Feb. 2, 2011 PCRX Common Stock Warrant (Right to Buy)→ Common Stock (20,220) 20,220 Indirect
Feb. 2, 2011 PCRX Common Stock Warrant (Right to Buy)→ Common Stock (708) 708 Indirect
Feb. 2, 2011 PCRX Common Stock Warrant (Right to Buy)→ Common Stock (843) 843 Indirect
Feb. 2, 2011 PCRX Common Stock Warrant (Right to Buy)→ Common Stock (20,069) 20,069 Indirect
Feb. 2, 2011 PCRX Convertible Promissory Notes→ Common Stock (344,355) 344,355 Indirect
Feb. 2, 2011 PCRX Convertible Promissory Notes→ Common Stock (12,058) 12,058 Indirect
Feb. 2, 2011 PCRX Convertible Promissory Notes→ Common Stock (14,366) 14,366 Indirect
Feb. 2, 2011 PCRX Convertible Promissory Notes→ Common Stock (341,788) 341,788 Indirect
Feb. 2, 2011 PCRX Convertible Promissory Notes→ Common Stock (129,445) 129,445 Indirect
Feb. 2, 2011 PCRX Convertible Promissory Notes→ Common Stock (5,400) 5,400 Indirect
Feb. 2, 2011 PCRX Convertible Promissory Notes→ Common Stock (128,479) 128,479 Indirect
Feb. 2, 2011 PCRX Convertible Promissory Notes→ Common Stock (4,533) 4,533 Indirect
Feb. 2, 2011 PCRX Stock Option (Right to Buy)→ Common Stock (4,649) 4,649 Direct
Feb. 2, 2011 PCRX Stock Option (Right to Buy)→ Common Stock (1,394) 1,394 Direct